A de novo splice donor site mutation causes in-frame deletion of 14 amino acids in the proteolipid protein in Pelizaeus-Merzbacher disease

Ann Neurol. 1999 Jul;46(1):112-5. doi: 10.1002/1531-8249(199907)46:1<112::aid-ana16>3.0.co;2-u.

Abstract

Pelizaeus-Merzbacher disease (PMD) is a leukodystrophy associated with mutations in the proteolipid protein (PLP) gene. Jimpy is a mouse model of human PMD, and a splice site mutation in Jimpy causes the deletion of exon 5 from the PLP mRNA, producing a truncated form of PLP. We describe a de novo point mutation at the 5' splice donor site of exon 5 in a 17-year-old male with PMD, which results in the skipping of 42 base pairs of exon 5. The mutation removes only 14 amino acids in-frame of PLP. This is a novel splice donor site mutation in the human PLP gene. Moreover, the results indicate that the 14-amino acid deletion in the PLP is responsible for oligodendrocyte cell death and the development of PMD.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Alternative Splicing / genetics*
  • Amino Acid Sequence
  • Base Sequence
  • Diffuse Cerebral Sclerosis of Schilder / genetics*
  • Humans
  • Male
  • Molecular Sequence Data
  • Mutation / genetics
  • Pedigree
  • Sequence Deletion*